학술논문
Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, February 2021, 144:291-301)
Subject
Language
English
ISSN
18790852
09598049
09598049